Furthermore, in bladder cancer patients, risk scores were inversely linked with the expression levels of immune marker genes (CD8A, CD80, etc.)and immune activation‐related genes (IL6, IFNG, etc.; Figure 6D,E). The gene discussed is IL6; the disease is urinary bladder carcinoma.